No Picture
News

Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag

– Arena will receive $800M upfront, and is eligible to receive low double-digit tiered royalties, plus up to $400M in milestone payments- United Therapeutics will receive exclusive, worldwide rights to ralinepag – a potential best-in-class agent for th… […]

No Picture
News

Evofem Biosciences to Present at Piper Jaffray Healthcare Conference on November 27, 2018

SAN DIEGO, Nov. 15, 2018 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”) announced today that the Company will present at the 30th Annual Piper Jaffray Healthcare Conference, as follows:
Date:
Tuesday, November… […]

No Picture
News

Torrey Pines Investment’s i2020 Accelerator to Advance Snap Bio’s Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases

SAN DIEGO, Nov. 15, 2018 /PRNewswire/ — Torrey Pines Investment announced today that Snap Bio, Inc. has joined its early drug discovery ecosystem through its i2020 Accelerator specialty investment framework, which includes a three-way partnership w… […]

No Picture
News

Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

SAN DIEGO and VANCOUVER, British Columbia, Nov. 13, 2018 /PRNewswire/ — Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage … […]